ATE367810T1 - Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren - Google Patents
Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäurenInfo
- Publication number
- ATE367810T1 ATE367810T1 AT02726156T AT02726156T ATE367810T1 AT E367810 T1 ATE367810 T1 AT E367810T1 AT 02726156 T AT02726156 T AT 02726156T AT 02726156 T AT02726156 T AT 02726156T AT E367810 T1 ATE367810 T1 AT E367810T1
- Authority
- AT
- Austria
- Prior art keywords
- vitamin
- polyunsaturated fatty
- isoflavones
- prevention
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 208000001132 Osteoporosis Diseases 0.000 title abstract 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 title abstract 2
- 235000008696 isoflavones Nutrition 0.000 title abstract 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title abstract 2
- 150000002515 isoflavone derivatives Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229930003316 Vitamin D Natural products 0.000 abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 2
- 229930003448 Vitamin K Chemical class 0.000 abstract 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Chemical class CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 2
- 235000019166 vitamin D Nutrition 0.000 abstract 2
- 239000011710 vitamin D Substances 0.000 abstract 2
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 2
- 235000019168 vitamin K Nutrition 0.000 abstract 2
- 239000011712 vitamin K Chemical class 0.000 abstract 2
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 2
- 229940046008 vitamin d Drugs 0.000 abstract 2
- 229940046010 vitamin k Drugs 0.000 abstract 2
- ZWSNUPOSLDAWJS-QNDFHXLGSA-N 6,7-dihydroxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2coc3cc(O)c(O)cc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O ZWSNUPOSLDAWJS-QNDFHXLGSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Botany (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01106520 | 2001-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE367810T1 true ATE367810T1 (de) | 2007-08-15 |
Family
ID=8176795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02726156T ATE367810T1 (de) | 2001-03-15 | 2002-03-11 | Zusammensetzung zur prävention von osteoporose bestehend aus einer kombination aus isoflavonen und polyungesättigten fettsäuren |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7635692B2 (de) |
| EP (3) | EP1370257B1 (de) |
| JP (1) | JP4646491B2 (de) |
| KR (1) | KR100875800B1 (de) |
| CN (1) | CN100389765C (de) |
| AT (1) | ATE367810T1 (de) |
| BR (1) | BRPI0208103B8 (de) |
| CA (1) | CA2440261C (de) |
| DE (1) | DE60221367T2 (de) |
| ES (1) | ES2289097T3 (de) |
| MX (1) | MXPA03008137A (de) |
| WO (1) | WO2002074308A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003068218A1 (en) * | 2002-02-15 | 2003-08-21 | N.V. Nutricia | Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| ITMI20022723A1 (it) * | 2002-12-20 | 2004-06-21 | Marfarma S R L Ora Marfarma Holding Spa | Composizioni per il trattamento della sindrome post-menopausa. |
| EP1732605B1 (de) * | 2004-03-29 | 2019-05-08 | Wyeth LLC | Multivitamin- und mineral-nahrungsergänzungsmittel |
| CN100351248C (zh) * | 2004-07-05 | 2007-11-28 | 南京大学 | 染料木素衍生物及其制法和用途 |
| US7601370B2 (en) | 2004-07-28 | 2009-10-13 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
| EP1853252B1 (de) * | 2005-02-15 | 2010-09-08 | DSM IP Assets B.V. | Zusammensetzungen mit polysacchariden |
| US20080279935A1 (en) * | 2005-02-18 | 2008-11-13 | Swg Invest As | Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base |
| DE102005011779A1 (de) * | 2005-03-11 | 2006-09-14 | Bayer Healthcare Ag | Endoparasitizide Mittel |
| US20090221690A1 (en) * | 2006-02-28 | 2009-09-03 | Council Of Scientific And Industrial Research | Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof |
| BRPI0708361A2 (pt) * | 2006-02-28 | 2011-05-24 | Nestec S.A | composições e métodos para a indução de crescimento ósseo e para a inibição de perda óssea |
| EP2004161B8 (de) * | 2006-04-12 | 2013-04-17 | Unilever PLC | Orale zusammensetzung mit dha und genistein zur verbesserung der hauteigenschaften |
| WO2007115934A1 (en) * | 2006-04-12 | 2007-10-18 | Unilever Plc | Oral composition with an antiageing effect on the skin |
| ES2391305T3 (es) * | 2006-04-12 | 2012-11-23 | Unilever N.V. | Composición oral que comprende un ácido graso poliinsaturado y ácido salicílico para obtener un efecto antiinflamatorio en la piel |
| WO2007128461A1 (en) * | 2006-05-10 | 2007-11-15 | Dsm Ip Assets B.V. | Animal food composition comprising genistein and polyunsaturated fatty acids |
| US20070298079A1 (en) * | 2006-06-26 | 2007-12-27 | Tropicana Products, Inc. | Food fortified with omega-3 fatty acids |
| EP2046312B1 (de) * | 2006-07-14 | 2020-02-19 | Kaydence Pharma AS | Pharmazeutische und nutrazeutische produkte mit vitamin k2 |
| EP1897530A1 (de) * | 2006-09-08 | 2008-03-12 | DSMIP Assets B.V. | Hautpflegezusammensetzung |
| EP2129373B1 (de) * | 2007-04-02 | 2013-05-22 | DSM IP Assets B.V. | Verwendung von Genistein zur Behandlung von trockenem Auge |
| US8211947B2 (en) * | 2008-01-28 | 2012-07-03 | Guillermo Selman-Housein Sosa | Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
| CN101537170B (zh) * | 2008-03-17 | 2012-05-30 | 哈药集团制药六厂 | 一种预防骨质疏松和骨关节病的组合物 |
| CN101574338B (zh) * | 2008-05-05 | 2012-01-11 | 上海医药工业研究院 | 一种抑制芳香化酶活性的药物组合物及其应用 |
| US8999962B2 (en) | 2008-06-03 | 2015-04-07 | John Ray Biffin | Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin K |
| TR201004464A2 (tr) * | 2010-06-03 | 2012-11-21 | B�Lg�� Mahmut | Kemik erimesi için formülasyon. |
| CN102356877A (zh) * | 2011-10-14 | 2012-02-22 | 李泼 | Cbp养钙冲剂 |
| WO2013089654A1 (en) * | 2011-12-16 | 2013-06-20 | Mahmut Bilgic | Effervescent formulations comprising genistein |
| FR3005419B1 (fr) | 2013-05-13 | 2015-09-04 | Agronomique Inst Nat Rech | Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux |
| JP6468617B2 (ja) * | 2014-12-17 | 2019-02-13 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 甲状腺機能亢進症を減少させるための方法および組成物 |
| CN109527538A (zh) * | 2018-11-07 | 2019-03-29 | 云南金霓尔生物科技有限公司 | 一种治疗骨质疏松促进吸收的营养剂及其制备方法 |
| CN112401066B (zh) * | 2020-11-18 | 2022-10-28 | 乖宝宠物食品集团股份有限公司 | 一种利于维持骨骼健康的宠物食品 |
| CN112790278B (zh) * | 2021-01-22 | 2022-10-28 | 乖宝宠物食品集团股份有限公司 | 一种维持骨骼健康的全价宠物罐头食品 |
| NO349080B1 (en) * | 2023-04-26 | 2025-09-15 | Epax Norway As | Very long chain fatty acids for use in mineralization |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04253908A (ja) * | 1990-12-28 | 1992-09-09 | Nippon Oil & Fats Co Ltd | 骨粗鬆症治療薬 |
| GB9112052D0 (en) * | 1991-06-05 | 1991-07-24 | Efamol Holdings | Fatty acid treatment |
| GB9217780D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
| DE19503190A1 (de) * | 1995-02-01 | 1996-08-08 | Dietl Hans | Mittel zur Beeinflussung von Störungen der Knochenbildung |
| JP3250071B2 (ja) * | 1997-06-26 | 2002-01-28 | 株式会社ホーネンコーポレーション | 抗骨粗鬆症組成物 |
| IT1299191B1 (it) * | 1998-06-23 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa |
| US6150399A (en) * | 1998-06-30 | 2000-11-21 | Abbott Laboratories | Soy-based nutritional products |
| JP2000191526A (ja) * | 1998-12-25 | 2000-07-11 | Marumiya:Kk | 骨形成促進及び抗骨粗鬆症組成物 |
| AU4402600A (en) * | 1999-05-18 | 2000-12-05 | Rawlings, Anthony V. | Fat containing products |
| FR2817866B1 (fr) * | 2000-12-13 | 2005-01-07 | Theramex | Procede d'extraction de melanges flavoniques et utilisation des melanges ainsi obtenus en dermocosmetique, en alimentation et en pharmacie |
-
2002
- 2002-03-11 ES ES02726156T patent/ES2289097T3/es not_active Expired - Lifetime
- 2002-03-11 AT AT02726156T patent/ATE367810T1/de not_active IP Right Cessation
- 2002-03-11 EP EP02726156A patent/EP1370257B1/de not_active Expired - Lifetime
- 2002-03-11 DE DE60221367T patent/DE60221367T2/de not_active Expired - Lifetime
- 2002-03-11 EP EP07014063A patent/EP1854462A1/de not_active Withdrawn
- 2002-03-11 CA CA2440261A patent/CA2440261C/en not_active Expired - Lifetime
- 2002-03-11 MX MXPA03008137A patent/MXPA03008137A/es active IP Right Grant
- 2002-03-11 JP JP2002573015A patent/JP4646491B2/ja not_active Expired - Fee Related
- 2002-03-11 WO PCT/EP2002/002646 patent/WO2002074308A1/en not_active Ceased
- 2002-03-11 EP EP07014076A patent/EP1852115A1/de not_active Withdrawn
- 2002-03-11 KR KR1020037012046A patent/KR100875800B1/ko not_active Expired - Fee Related
- 2002-03-11 US US10/471,890 patent/US7635692B2/en not_active Expired - Fee Related
- 2002-03-11 CN CNB028066634A patent/CN100389765C/zh not_active Expired - Fee Related
- 2002-03-11 BR BR0208103-2 patent/BRPI0208103B8/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20040082523A1 (en) | 2004-04-29 |
| BRPI0208103B8 (pt) | 2021-05-25 |
| MXPA03008137A (es) | 2003-12-12 |
| WO2002074308A1 (en) | 2002-09-26 |
| KR100875800B1 (ko) | 2008-12-24 |
| CA2440261A1 (en) | 2002-09-26 |
| CA2440261C (en) | 2014-05-27 |
| EP1370257B1 (de) | 2007-07-25 |
| CN1501799A (zh) | 2004-06-02 |
| DE60221367D1 (de) | 2007-09-06 |
| JP2004532829A (ja) | 2004-10-28 |
| BR0208103A (pt) | 2004-03-02 |
| DE60221367T2 (de) | 2008-04-03 |
| JP4646491B2 (ja) | 2011-03-09 |
| KR20040025906A (ko) | 2004-03-26 |
| ES2289097T3 (es) | 2008-02-01 |
| BRPI0208103B1 (pt) | 2018-02-14 |
| US7635692B2 (en) | 2009-12-22 |
| EP1852115A1 (de) | 2007-11-07 |
| EP1854462A1 (de) | 2007-11-14 |
| CN100389765C (zh) | 2008-05-28 |
| EP1370257A1 (de) | 2003-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60221367D1 (de) | ZUSAMMENSETZUNG ZUR PRÄVENTION VON OSTEOPOROSE bestehend aus EINER KOMBINATION AUS ISOFLAVONEN UND POLYUNGESÄTTIGTEN FETTSÄUREN | |
| WO2003005981A3 (de) | Zusammensetzungen auf wachsbasis und verwendung als körperpflegemittel | |
| BR0100765A (pt) | Processo para o processamento de composições de borracha contendo ácidos graxos de soja, ácidos graxos de girassol e suas misturas | |
| ATE334978T1 (de) | Zusammensetzungen und therapeutische anwendungen von isoflavonen und deren analoga | |
| BR0213546A (pt) | Composições ácidas de sanitização e limpeza contendo ácidos carboxìlicos protonados | |
| DE69916414D1 (de) | Sojazubereitungen und deren verwendung zur gesundheitsförderung | |
| ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
| IL126433A0 (en) | Compositions comprising isoflavones and their preparation | |
| DE60125825D1 (de) | Parfümzusammensetzungen | |
| HUP0401144A2 (hu) | Enterális tápszerkészítmények | |
| BR9813811A (pt) | "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo" | |
| EA200200880A1 (ru) | Агротехническая композиция | |
| DK0950410T3 (da) | Konjugeret linolsyresammensætninger | |
| BR0311764A (pt) | Composição herbicida | |
| BR0111210A (pt) | Composição para o tratamento e/ou prevenção de osteoporose e/ou doenças de juntas inflamatórias | |
| BRPI0407950A (pt) | processo para a preparação de uma composição de higiene pessoal | |
| ATE515252T1 (de) | Pseudokörpergeruchszusammensetzung | |
| ATE381530T1 (de) | Cycloalkancarbonsäurederivate als duftstoffe mit moschuscharakter | |
| FR2804023B1 (fr) | Complement nutritionnel a base d'huile de pepins de cassis | |
| BR9803251A (pt) | Agente de embranquecimento fluorescente | |
| BR0107351A (pt) | Composição perfumante sem álcool | |
| BR0116179A (pt) | Composição despejável, processo de preparação de uma composição despejável e uso da composição | |
| DE69809791D1 (de) | Schwindungreduzierendes mittel für zementzusammensetzungen | |
| BRPI0512794A (pt) | sistema de pré-mistura anidra, e, método para dispersar pigmento para formar uma pré-mistura | |
| BR0312177A (pt) | Composição condicionadora dos cabelos, método de tratamento dos cabelos e uso de uma argila hidrofobicamente modificada |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |